Cancer and aging are integrally related. Cancer incidence and mortality increase with age, with most cancer diagnoses and deaths occurring in patients aged 65 and older. The aging of the Baby Boomer population, along with an overall increase in life expectancy, points to a doubling of the U.S. population over age 65 by the year 2030. This demographic shift, combined with the known association of cancer and aging, is expected to bring about a rapid growth in the older cancer-patient population. It is clear that geriatric principles must become part of oncology care. The evaluation and development of treatment recommen- tions for an older adult with cancer can be challenging for many reasons. Tumor biology and response to therapy are affected by age. In addition, age-related factors may impact treatment patterns, tolerance, and efficacy. These age-related factors include functional status declines, comorbid conditions, changes in cognitive function, weakening of organ function, decreases in physiologic reserve, and faltering social support.
Providing a frame of reference for the ongoing dialogue in the field of geriatric oncology, this is a major reference work for basic, population, and clinical scientists interested in the issue and for practices ministering to older ...
In addition to serving as core reading for oncologists and hematologists, the book will also be a useful work for other healthcare professionals who provide oncology care, including surgeons, radiation oncologists, palliative care doctors, ...
Spearheaded by world experts in geriatric oncology from Memorial Sloan Kettering Cancer Center in New York, this book is the definitive resource for oncologists and related clinicians to meet the demands of clinical management along the ...
This issue of Clinics in Geriatric Medicine, devoted to Geriatric Oncology, is guest edited by Drs. Harvey J. Cohen and Arati V. Rao of Duke University Medical Center.
This book is intended as a comprehensive resource for clinicians and researchers seeking in-depth information on geriatric oncology.
This volume highlights research issues specific to geriatric oncology in the field of carcinogenesis and cancer prevention and treatment, based on the biologic interactions of cancer and age.
This affects a wide spectrum of research and practice, anywhere from basic research to health care organization. Core examples of these close associations are addressed in this book.
Br J Haematol 2007;138(2):176–85. Morris CL, Siegel E, Barlogie B, et al. Mobilization of CD34 cells in elderly patients (/ 70 years) with multiple myeloma: influence of age, prior therapy, platelet count and mobilization regimen.
Klein, M.K. 2001. “Tumors of the female reproductive system.” In Small animal clinical oncology, 3rd ed., by S.J. Withrow and E.G. MacEwen, pp. 445–454. Philadelphia: Saunders. McDonald, M. Ethics and conflict of interest.
Measuring quality of life in the frail elderly. Journal of Clinical Epidemiology, 46(12), 1433–1444. Gwede, C., Friedland, J., Johnson, D., Casey, L., Cantor, A., Sauder, B., & Beres, K. L. (1996). Validation of the quality of ...